Feature | July 26, 2013

Healthcare Decision Support and IBM Watson — Market Shares, Strategies, Forecasts

July 26, 2013 — Worldwide healthcare cognitive computing markets are poised to achieve continuing growth as the healthcare delivery system responds to new products. Growth is achieved in response to changing technology, better analytics, new information systems that leverage natural language and changing market conditions.

Healthcare decision support markets consist of traditional market participants led by McKesson and Watson from IBM. IBM Watson offers structured and unstructured data in combination. This represents a major breakthrough in what kind of decision support can be offered.

IBM Watson can provide a far more differentiated testing assessment and knows what tests are relevant to further characterize a particular patient condition and what tests are not. Having an assistant that is able to have read the latest journal articles and is loaded with medical information to recommend what tests may be relevant in a particular situation is a great help to physicians. Wrong tests, tests that are not useful in a particular situation, account for 30 percent of the costs of healthcare delivery in the United States. 

IBM Watson is initiating a new era of cognitive computing that extends the tabulator and application program intensive enabling new market opportunities based on cognitive performance. Watson is comprised of a powerful core engine. The first purpose that Watson has been put to is to improve healthcare delivery. 

For more information: www.researchandmarkets.com/research/v5ccjm/healthcare

Related Content

Elekta and IBM Watson Health Bringing Artificial Intelligence to Oncology
News | Oncology Diagnostics | January 31, 2018
Elekta announced it is collaborating with IBM Watson Health to offer Watson for Oncology with Elekta’s cancer care...
MedCurrent Rolls Out OrderWise Clinical Decision Support Platform With iRefer Guidelines
Technology | Clinical Decision Support | January 29, 2018
Primary care providers and hospital doctors around the world can now access the imaging referral guidelines from the U....
National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC).

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC). 

Feature | Clinical Decision Support | January 18, 2018
January 18, 2018 — Change Healthcare announced the acquisition of National Decision Support Company (NDSC), a leader
News | Clinical Decision Support | January 12, 2018
January 12, 2018 — GE Healthcare has entered into a strategic, long-term partnership with Roche to jointly develop an
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Mirada Medical and Optellum Debut AI-Based Lung Cancer Diagnosis Solution at RSNA 2017
News | Computed Tomography (CT) | December 14, 2017
Optellum, a high-tech startup in lung cancer and machine learning, and Mirada Medical recently announced a partnership...
HealthMyne Highlights Value of Quantitative Data in Oncology Reads at RSNA 2017
News | Clinical Decision Support | November 17, 2017
November 17, 2017 — At the 2017 Radiological Society of North America (RSNA) conference, HealthMyne will demonstrate
Intelerad Announces Partnership With MedCurrent
News | Clinical Decision Support | November 13, 2017
November 13, 2017 — Intelerad Medical Systems announced a partnership that will see MedCurrent’s OrderWise...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Overlay Init